1. Home
  2. Live Updates
  3. Disease care

Live Breaking News & Updates on Disease care

Stay informed with the latest breaking news from Disease care on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Disease care and stay connected to the pulse of your community

Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's disease

PURCHASE - Cognition Therapeutics, Inc., , a clinical stage company developing drugs that treat neurodegenerative disorders, provided a recap of the virtual KOL event hosted on April 12, 2024...

Amsterdam , Noord-holland , Netherlands , Anton-porsteinsson , Jort-vijverberg , Mike-moyer , Casey-mcdonald , Martinj-sadowski , Lisa-ricciardi , Company-or-cognition , Securities-exchange-commission , Cognition-therapeutics-inc

Novel Agent Curbs Alzheimer's-Related Agitation

AXS-05, a combination of dextromethorphan and bupropion, led to a rapid and sustained improvement in agitation related to Alzheimer's disease in the phase 3 ACCORD trial.

Pennsylvania , United-states , Mansfield , New-york , University-of-rochester , American , Antonp-porsteinsson , Glenr-finney , Rebecca-edelmayer , Alzheimer-association , Drug-administration , American-academy-of-neurology

Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer's Disease on April 12, 2024 -April 01, 2024 at 07:31 am EDT

NEW YORK, April 01, 2024 -- Cognition Therapeutics, Inc. , a clinical stage company developing drugs that treat neurodegenerative disorders, today announced it will host a virtual KOL event on...

United-states , Amsterdam , Noord-holland , Netherlands , Poland , Iceland , American , Casey-mcdonald , Anton-porsteinsson , Martinj-sadowski , Mike-moyer , Jort-vijverberg

Alzheimer's: Pre-symptom biomarker changes could help early diagnosis

Alzheimer's: Pre-symptom biomarker changes could help early diagnosis
medicalnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalnewstoday.com Daily Mail and Mail on Sunday newspapers.

China , Chinese , Emily-clark , Time-white-getty , Clare-sexton , Claire-sexton , Emer-macsweeney , Education-program , Cognition-health , Alzheimer-association , University-of-rochester-medical-center , World-health-organization

Coming up on Connections: Wednesday, December 20, 2023

Coming up on Connections: Wednesday, December 20, 2023
wxxinews.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wxxinews.org Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Unity-hospital , Rochester , University-of-rochester-medical-center , Eric-logan , Matt-mann , David-gill , Linda-flosenzer , Mimi-devinney , Anton-porsteinsson , Katy-allen

What should we know about diagnosis and symptoms for dementia and Alzheimer's disease?

What should we know about diagnosis and symptoms for dementia and Alzheimer's disease?
wxxinews.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wxxinews.org Daily Mail and Mail on Sunday newspapers.

New-york , United-states , University-of-rochester-medical-center , Unity-hospital , David-gill , Anton-porsteinsson , Department-of-neurology , Alzheimer-association , University-of-rochester-alzheimer-disease-care , York-state-department-of-health , Education-program , Memory-center

Penfield man living with Alzheimer's hopes new study will lead to change

Jim Gulley, a man from Penfield, has been living with Alzheimer's Disease for eight years.

Rose-gulley , Jim-gulley , Anton-porsteinsson , Education-program , University-of-rochester , Disease-care , New-york , United-states , Health-medical-pharma , Rochester , Penfield , Lecanemab

How dementia differs from normal memory loss through aging

The risk of developing dementia comes with age, but dementia is not a normal part of aging.

Missouri , United-states , University-of-rochester-medical-center , New-york , Anton-porsteinsson , Henry-petry , Amanda-lewton , National-institutes-of-health , Education-program , Freeman-center , Rochester-medical-center , Disease-care

Syphilis Disease Management- Role of DLI in Clinical Trial Management, Regulatory Consulting, and Price Reimbursement

Syphilis Disease Management- Role of DLI in Clinical Trial Management, Regulatory Consulting, and Price Reimbursement
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Pune , Maharashtra , India , London , City-of , United-kingdom , Viman-nagar , Market-research-services , Lexicon-pharmaceuticals , Disease-landscape-insights , Venereal-disease-research-laboratory-test , Vaccine-development

Microfluidics Market Size to Expand at a CAGR of 16.5% to Reach Valuation of USD 73.16 Billion by 2028

/PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Microfluidics Market Size, Share & Trends Analysis Report...

India , Pune , Maharashtra , London , City-of , United-kingdom , Vishal-sawant , Abbott-laboratories , Brandessence-market-research , Agilent-technologies-inc , Direction-of-special-solutions , Lexicon-pharmaceuticals